Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Financial Officer

Chief Medical Officer

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, develops therapeutics and vaccines to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed to treat autoimmune conditions. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; and TNX-102 SL, a CNS product candidate to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a recombinant protein enzyme to treat cocaine intoxication. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, develops therapeutics and vaccines to treat and prevent h...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-06-29	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-03-25	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-09-28	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-06-30	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2021-06-30	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-05-25	Premium	bought	Premium	Premium	Premium	-
2021-03-24	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-01-07	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2020-12-30	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2020-08-31	Premium	bought	Premium	Premium	Premium	-
2020-08-20	Premium	bought	Premium	Premium	Premium	-
2020-08-17	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2020-08-14	Premium	bought	Premium	Premium	Premium	-
2020-08-13	Premium	bought	Premium	Premium	Premium	-
2020-08-13	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2020-08-13	Premium	bought	Premium	Premium	Premium	-
2020-01-06	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2019-12-03	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2019-07-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2019-07-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2019-03-29	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2019-03-26	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2019-02-17	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2019-02-17	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

TNXP - Tonix Pharmaceuticals Holding Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for TNXP